Recognition and Treatment of Tardive Dyskinesia in Individuals with Intellectual Disability - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/33414976/

Individuals with intellectual disability (ID) commonly suffer from comorbid psychiatric and behavioral disorders that are frequently treated by antipsychotic medications. All individuals exposed to first- and second/third- generation antipsychotics are at risk for developing tardive dyskinesia (TD), characterized by abnormal, involuntary movements of the mouth/tongue/jaw, trunk, and extremities.